Fingerprint
Dive into the research topics of 'Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pedro J. Beltran, Frank J. Calzone, Petia Mitchell, Young Ah Chung, Elaina Cajulis, Gordon Moody, Brian Belmontes, Chi Ming Li, Steven Vonderfecht, Victor E. Velculescu, Guorong Yang, Jingwei Qi, Dennis J. Slamon, Gottfried E. Konecny
Research output: Contribution to journal › Article › peer-review